AGPAT2 抗体 (C-Term)
Quick Overview for AGPAT2 抗体 (C-Term) (ABIN630343)
抗原
See all AGPAT2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
特异性
- AGPAT2 antibody was raised against the C terminal of AGPAT2
-
纯化方法
- Purified
-
免疫原
- AGPAT2 antibody was raised using the C terminal of AGPAT2 corresponding to a region with amino acids LEAIPTSGLTAADVPALVDTCHRAMRTTFLHISKTPQENGATAGSGVQPA
-
-
-
-
应用备注
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
AGPAT2 Blocking Peptide, (ABIN940260), is also available for use as a blocking control in assays to test for specificity of this AGPAT2 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AGPAT2 antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
别名
- AGPAT2
-
背景
- AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.
-
分子量
- 27 kDa (MW of target protein)
抗原
-